BillionToOne, Inc. Class A BLLN 深 滬
已收盤 02-06 16:00:00 美东时间
90.61
+5.460
+6.41%
華盛通- 最 高91.01
- 今 開85.50
- 成交量 10.09万股
- 最 低 84.14
- 昨 收 85.15
- 總市值 41.47亿
- 52周最高 138.70
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 80.00
- 委 比 -31.03%
- 總股本 4576.88万
- 歷史最高 138.70
- 量 比 0.57
- 振 幅 8.07%
- 歷史最低 80.00
- 每 手 1
- 風險率 12.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With BillionToOne Shares Tuesday?
BillionToOne shares traded higher premarket on possible continued momentum Tuesday before flattening at the beginning of the session.
01-13 22:43
BillionToOne shares are trading higher. The company reiterated its FY25 guidance and initiated FY26 financial guidance.
BillionToOne shares are trading higher. The company reiterated its FY25 guidanc...
01-13 03:55
BillionToOne Reiterates 2025 Revenue Guidance Of $293M-$299M; Projects 2026 Revenue Of $415M-$430M
BillionToOne, Inc. (NASDAQ:BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reiterated the full year 2025 guidance of $293
01-12 21:17
美股周涨跌榜 | 奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%
奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%，此前宣布高品位银钻探结果；德纳维制药周涨近42%，获制药巨头赛诺菲安万特收购>>
2025-12-27 09:57
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
BTIG Reiterates Buy on BillionToOne, Maintains $160 Price Target
BTIG analyst Mark Massaro reiterates BillionToOne (NASDAQ:BLLN) with a Buy and maintains $160 price target.
2025-12-10 18:25
BillionToOne shares are trading lower after the company reported mixed Q3 financial results.
BillionToOne shares are trading lower after the company reported mixed Q3 finan...
2025-12-10 05:21
BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate
BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.16 by 37.5 percent. The company reported quarterly sales of $83.500 million which beat the
2025-12-10 05:06
Earnings Scheduled For December 9, 2025
Companies Reporting Before The Bell • TH International (NASDAQ:THCH) is likely ...
2025-12-09 19:11
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
2025-12-02 09:50
